Castlight Health, inc. (NYSE:CSLT) reported Q2 2017 earnings this Afternoon, coming in at ($0.07) per share, beating Wall Street’s estimates of ($0.09) per Share. Revenue for the quarter came in at $32.10 million beating analyst estimates of $31.14 million
Analyst Coverage For Castlight Health, inc. (NYSE:CSLT)
These are 1 Sell Rating, 5 Hold Ratings, 2 Buy Ratings .
The current consensus rating for Castlight Health, inc. (NYSE:CSLT) is Hold (Score: 2.13) with a consensus target price of $4.46 , a potential (2.63% upside)Recent Insider Trading for Castlight Health, inc. (NYSE:CSLT)
- On 5/18/2017 Mangini Siobhan Nolan, CFO, sold 216 with an average share price of $3.60 per share and the total transaction amounting to $777.60.
- On 5/17/2017 Giovanni M Colella, Insider, sold 11,456 with an average share price of $3.75 per share and the total transaction amounting to $42,960.00.
- On 5/17/2017 John C Doyle, CEO, sold 6,548 with an average share price of $3.81 per share and the total transaction amounting to $24,947.88.
- On 5/17/2017 Mangini Siobhan Nolan, CFO, sold 2,765 with an average share price of $3.77 per share and the total transaction amounting to $10,424.05.
- On 5/17/2017 Priya Jain, CAO, sold 7,858 with an average share price of $3.65 per share and the total transaction amounting to $28,681.70.
- On 5/16/2017 Giovanni M Colella, Chairman, sold 3,793 with an average share price of $3.97 per share and the total transaction amounting to $15,058.21.
Recent Trading for Castlight Health, inc. (NYSE:CSLT) Shares of Castlight Health, inc. closed the previous trading session at 4.35 0.00 0.00% with 221,624 shares trading hands.